Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9


Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 2001

PDF Downloaded: 608


Stevens-Johnson syndrome and toxic epidermal necrolysis overlap associated with alternative medicine: A case report


Full Text PDF


Case Report

Author Details : Kushagra Sharma*, Joseph Saji

Volume : 6, Issue : 2, Year : 2019

Article Page : 53-54

https://doi.org/10.18231/j.ijpca.2019.010



Suggest article by email

Get Permission

Abstract

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) is rare, acute and life-threatening conditions usually associated with mucosal loss and can be caused by various medicines. Even it also may cause by took alternative medications from unregistered medical practitioner (Hakeem). It includes the severe form of mucosal dermatitis, and characterized by extensive epidermal blistering, it leads to epidermal necrosis and loss of the epidermis. They can also cause oral mucosa lesions. A 11 year old female patient admitted with the complain of headache, loose stool, haematuria, rashes with itching followed by mucosa loss throughout the body, including both face and hands, multiple ulcers present in the oral cavity. On laboratory investigation, abnormal values are:- White blood cell (11500/microliter) and SGOT (60 U/L), SGPT (86 U/L) levels are abnormally identified. Patient was treated with Injection Vancomycin 4ml in 60ml in Normal saline q.i.d. (4 times a day) for 10 days. Further changed to tablet Azithromycin 250 mg once daily for next 5 days. Injection Meropenum (8mL+12mL), Injection Lipomadol. Lidocaine and fusidic acid jelly application 3 times daily for lips and skin lesions was prescribed.

Keywords: Stevens - Johnson syndrome, Toxic Epidermal Necrolysis, Erythema dermatitis.



How to cite : Sharma K, Saji J, Stevens-Johnson syndrome and toxic epidermal necrolysis overlap associated with alternative medicine: A case report. Int J Pharm Chem Anal 2019;6(2):53-54


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.